Kapitalizacja Rynkowa Zmiana Data
AbbVie USD 508.97B 46.71B 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amarin USD 290M 51M 2025-12
AstraZeneca USD 213.88B 23.43B 2026-11
BioCryst Pharmaceuticals USD 2.54B 880M 2026-06
DBV Technologies USD 739M 491M 2026-09
GlaxoSmithKline GBP 74.11B 6.03B 2026-09
Halozyme Therapeutics USD 15.62B 3.09B 2026-11
Heron Therapeutics USD 238M 7M 2025-12
Ionis Pharmaceuticals USD 4.24B 3.18B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Novartis USD 292.09B 51.5B 2026-09